Searched for
PHARMACEUTICALS PVT LTD
India Inc wary of fresh trade headwinds as US weighs additional 12.5% tariffIndia faces a potential 12.5% US tariff on imports following a Section 301 investigation into forced labor import prohibitions. Industry le...- Strides Pharma sells majority stake in arm Pivot Path for Rs 100 croreStrides Pharma Science has divested a majority stake in its subsidiary, Pivot Path, for Rs 100 crore to a consortium led by Ascent Capital ...
- Trade disruptions, API dependence, compliance costs: Pharma MSMEs spell out policy priorities on World MSME DayIndian pharmaceutical MSMEs are facing immense pressure from rising costs, supply chain woes, and stringent regulations. Industry represent...
- India launches anti-dumping probe into electrical steel imports from China, 3 other nationsIndia has launched an anti-dumping investigation into electrical steel imports from China, Japan, Korea, and Russia. This move, prompted by...
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 24%When business updates start to come in or when some FMCG or auto companies indicate that things are not all good in the rural space, we may...
- These large- mid- and small-cap stocks can give more than 25% return in 1 year, according to analystsAs the bulls attempt another serious comeback, the market again faces a familiar question: Are valuations still too high, or have they reac...
- Government okays Skymap Pharmaceuticals' Rs 121-cr bid to buy IMPCLThe government has approved the sale of Indian Medicines Pharmaceutical Corporation Ltd. Skymap Pharmaceuticals Pvt Ltd will acquire the co...
- For both the compulsive trader and careful investor: 25 stocks to watch if risk appetite returns; some with upside potential, some notIf the price of crude oil softens, Indian equities may again see a risk-on phase. Tariff concerns are no longer the central issue; the larg...
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 25%Here’s a thing investors in equity need to keep in mind. A large part of the upmove one might see in the next one or two trading sessions w...
- RFBL Flexi Pack fixes price band at Rs 47-50 for IPO, to hit markets on May 12Flexible packaging materials manufacturer RFBL Flexi Pack Ltd on Saturday announced a price band of Rs 47-50 per equity share for its initi...
- Bombay HC backs GSK in Paxil trademark row against Shreya Life SciencesThe Indian subsidiary of the UK-based GSK PLC had urged the court to cancel the mark used by the local company in pharmaceutical and medici...
- Bankruptcy court admits BSE-listed Supha Pharmachem under Insolvency Resolution ProcessThe Mumbai bench of the National Company Law Tribunal has admitted Supha Pharmachem into the Corporate Insolvency Resolution Process (CIRP)...
- CCI approves proposed merger of Girnar group firms with Artivatic Data LabsFair trade regulator CCI has approved the merger of four Girnar group entities, including those operating CarDekho and InsuranceDekho, into...
- Paracetamol to PAN-D: CDSCO finds over 50 sub-standard drugs. Check full list of medicinesThe Central Drugs Standard Control Organisation (CDSCO) has flagged over 50 drugs, including Paracetamol, as 'not of standard quality'. The...
- ET Leadership Excellence Awards 2023, Celebrates the Business Leaders
- CCI clears deal involving Sekhmet Pharmaventures, Optimus DrugsIn a tweet on Friday, the watchdog said it has approved acquisition of majority shareholding in Optimus Drugs by Sekhmet Pharmaventures as ...
- 16 'polluting' units in Ahmedabad get closure noticesGujarat Pollution Control Board (GPCB) has issued closure notices to 16 industrial units in the city for not observing norms to check pollu...
- Chhattisgarh sterilisation deaths: Officer says antibiotics had Mumbai pharma stampChhattisgarh health department on Thursday raided two pharma companies, Mahawar Pharma Pvt Ltd at Raipur and Kavita Pharmaceuticals in Bila...
- Eight FDI proposals in pharma for Rs 1,842.55 cr approved: Srikant Kumar JenaGovt said a total of eight proposals amounting to Rs 1,842.55 cr relating to FDI in brownfield pharma sector were approved in August this y...
- Invida Holdings Pvt Ltd acquires Shalaks' dermatology, primary care portfolioInvida Holdings Pvt Ltd today said it has acquired the dermatology and primary care portfolio of Shalaks Pharmaceuticals Pvt Ltd.
Load More
